| Referências: |
1. Meyer J.S and Quenzer LF. Psychopharmacology: drugs, the brain, and behavior. Sinauer
Associates. Sunderland, MA, 2005.
2. CME Institute of Physicians Postgraduate Press, O'Brien CP, Koob GF, Mee-Lee D, Rosenthal
RN. New developments in addiction treatment. J Clin Psychiatry. 67(11): 1801-12, 2006.
3. Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does and doesn't do.
Curr Opin Pharmacol. 2007 Feb;7(1):69-76.
4. Logrip ML, Koob GF, Zorrilla EP. Role of corticotropin-releasing factor in drug addiction: potential
for pharmacological intervention. CNS Drugs. 2011 Apr;25(4):271-87.
5. Koob GF, Kenneth Lloyd G, Mason BJ. Development of pharmacotherapies for drug addiction: a
Rosetta stone approach. Nat Rev Drug Discov. 2009 Jun;8(6):500-15.
6. Lesscher HM, Vanderschuren LJ. Compulsive drug use and its neural substrates. Rev Neurosci.
2012;23(5-6):731-45.
7. Everitt BJ, Robbins TW. From the ventral to the dorsal striatum: Devolving views of their roles in
drug addiction. Neurosci Biobehav Rev. 2013 Feb 21. doi:pii: S0149-7634(13)00046-8.
10.1016/j.neubiorev.2013.02.010. [Epub ahead of print]
8. Pacheco, AD et al. Maternal crack cocaine use in rats leads to depressive- and anxiety-like
behavior, memory impairment, and increased seizure susceptibility in the offspring. European
Neuropsychopharmacology 44 (2021) 34–50.
9. Freitas-Santos, J et al. Effects of cocaine, nicotine, and marijuana exposure in Drosophila
melanogaster development: a systematic review and meta-analysis. Progress in
Neuropharmacology & Biological Psychiatry 134 (2024) 111049.
10. Cavalcante, MB et al. Crack cocaine inhalation increases seizure susceptibility by reducing
acetylcholinesterase activity. Epilepsy & Behavior 156 (2024) 109832.
|
